Cargando…

Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy

Detalles Bibliográficos
Autores principales: Pepe, Alessia, Meloni, Antonella, Rossi, Giuseppe, Dell'Amico, Maria Chiara, Capra, Marcello, Caruso, Vincenzo, Pitrolo, Lorella, Centra, Michele, Pepe, Pasquale, Cracolici, Eliana, Ricchi, Paolo, Lombardi, Massimo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106514/
http://dx.doi.org/10.1186/1532-429X-13-S1-O18
_version_ 1782204796107751424
author Pepe, Alessia
Meloni, Antonella
Rossi, Giuseppe
Dell'Amico, Maria Chiara
Capra, Marcello
Caruso, Vincenzo
Pitrolo, Lorella
Centra, Michele
Pepe, Pasquale
Cracolici, Eliana
Ricchi, Paolo
Lombardi, Massimo
author_facet Pepe, Alessia
Meloni, Antonella
Rossi, Giuseppe
Dell'Amico, Maria Chiara
Capra, Marcello
Caruso, Vincenzo
Pitrolo, Lorella
Centra, Michele
Pepe, Pasquale
Cracolici, Eliana
Ricchi, Paolo
Lombardi, Massimo
author_sort Pepe, Alessia
collection PubMed
description
format Text
id pubmed-3106514
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31065142011-06-03 Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy Pepe, Alessia Meloni, Antonella Rossi, Giuseppe Dell'Amico, Maria Chiara Capra, Marcello Caruso, Vincenzo Pitrolo, Lorella Centra, Michele Pepe, Pasquale Cracolici, Eliana Ricchi, Paolo Lombardi, Massimo J Cardiovasc Magn Reson Oral Presentation BioMed Central 2011-02-02 /pmc/articles/PMC3106514/ http://dx.doi.org/10.1186/1532-429X-13-S1-O18 Text en Copyright ©2011 Pepe et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Pepe, Alessia
Meloni, Antonella
Rossi, Giuseppe
Dell'Amico, Maria Chiara
Capra, Marcello
Caruso, Vincenzo
Pitrolo, Lorella
Centra, Michele
Pepe, Pasquale
Cracolici, Eliana
Ricchi, Paolo
Lombardi, Massimo
Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy
title Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy
title_full Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy
title_fullStr Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy
title_full_unstemmed Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy
title_short Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy
title_sort prospective comparison on cardiac iron by mr in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106514/
http://dx.doi.org/10.1186/1532-429X-13-S1-O18
work_keys_str_mv AT pepealessia prospectivecomparisononcardiacironbymrinthalassemiamajorpatientstreatedwithcombinationdeferiprondesferrioxamineversusdeferipronanddesferrioxamineinmonoterapy
AT meloniantonella prospectivecomparisononcardiacironbymrinthalassemiamajorpatientstreatedwithcombinationdeferiprondesferrioxamineversusdeferipronanddesferrioxamineinmonoterapy
AT rossigiuseppe prospectivecomparisononcardiacironbymrinthalassemiamajorpatientstreatedwithcombinationdeferiprondesferrioxamineversusdeferipronanddesferrioxamineinmonoterapy
AT dellamicomariachiara prospectivecomparisononcardiacironbymrinthalassemiamajorpatientstreatedwithcombinationdeferiprondesferrioxamineversusdeferipronanddesferrioxamineinmonoterapy
AT capramarcello prospectivecomparisononcardiacironbymrinthalassemiamajorpatientstreatedwithcombinationdeferiprondesferrioxamineversusdeferipronanddesferrioxamineinmonoterapy
AT carusovincenzo prospectivecomparisononcardiacironbymrinthalassemiamajorpatientstreatedwithcombinationdeferiprondesferrioxamineversusdeferipronanddesferrioxamineinmonoterapy
AT pitrololorella prospectivecomparisononcardiacironbymrinthalassemiamajorpatientstreatedwithcombinationdeferiprondesferrioxamineversusdeferipronanddesferrioxamineinmonoterapy
AT centramichele prospectivecomparisononcardiacironbymrinthalassemiamajorpatientstreatedwithcombinationdeferiprondesferrioxamineversusdeferipronanddesferrioxamineinmonoterapy
AT pepepasquale prospectivecomparisononcardiacironbymrinthalassemiamajorpatientstreatedwithcombinationdeferiprondesferrioxamineversusdeferipronanddesferrioxamineinmonoterapy
AT cracolicieliana prospectivecomparisononcardiacironbymrinthalassemiamajorpatientstreatedwithcombinationdeferiprondesferrioxamineversusdeferipronanddesferrioxamineinmonoterapy
AT ricchipaolo prospectivecomparisononcardiacironbymrinthalassemiamajorpatientstreatedwithcombinationdeferiprondesferrioxamineversusdeferipronanddesferrioxamineinmonoterapy
AT lombardimassimo prospectivecomparisononcardiacironbymrinthalassemiamajorpatientstreatedwithcombinationdeferiprondesferrioxamineversusdeferipronanddesferrioxamineinmonoterapy